Get the latest Science News and Discoveries

Insilico Medicine leadership presents on key issues in AI drug discovery at BIO International - EurekAlert


Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine (“Insilico”) will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of AI drug discovery

AI drug discovery

Photo of key issues

key issues

Photo of Insilico Medicine

Insilico Medicine

Related news:

News photo

Insilico Medicine introduces nach0: A one-stop LLM for chemical and biomedical tasks - EurekAlert

News photo

Insilico Medicine moves its headquarters to Boston - EurekAlert

News photo

Insilico Medicine receives IND approval from FDA for novel MAT2A inhibitor ISM3412 - EurekAlert